Ranking Year:
# | Company Name | Region | Tech Topics | Total |
|---|
1 | Patent: 4 | |||
2 | Patent: 3 | |||
3 | Patent: 1 | |||
4 | Patent: 1 | |||
5 | Patent: 1 |
Top 5 Key Players companies in Fexofenadine Hydrochloride
by Most Patent Filings in the Japan in 2019
The Fexofenadine Hydrochloride top 5 is Discovery PatSnap’ annual ranking of the top 5 Most Patent Filings Fexofenadine Hydrochloride Key Players in the Japan. Discovery has identified the top key players, startups & unicorns, fast-growings, news entrants in 2019, ranking from differnt perspectives, including patent filing intensity, academic research capability, news media heat. The company list is generated from various data types.
The hydrochloride salt form of fexofenadine, a carboxylated metabolic derivative of terfenadine and second generation, long-lasting selective histamine H1 receptor antagonist, with antihistaminic activity. Upon administration, fexofenadine competitively binds of peripheral H1-receptors in the gastrointestinal (GI) tract, blood vessels, and bronchial smooth muscle. This prevents binding of histamine to peripheral H1-receptors and prevents their activation. This prevents a histamine-mediated allergic reaction. Fexofenadine does not cross the blood-brain-barrier (BBB).
Page generation time:
Jul 21 2025